Results 261 to 270 of about 131,451 (349)

Computed Tomography Findings of Pulmonary Lymphoma in a Dog and Two Cats

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
This study was retrospective case series analysis of CT findings of pulmonary lymphoma in a dog and two cats. Of three pulmonary lymphoma cases, the distinguishing CT feature was a well‐defined lesion with distinct air bronchograms, pulmonary vessels, and homogeneous enhancement. ABSTRACT This case series assessed CT findings of pulmonary lymphoma in a
Toshiyuki Tanaka, Yusuke Wada, Takuya Kusaka, Mizuki Tomihari, Takashi Hasegawa   +4 more
wiley   +1 more source

HELLS inhibits autophagy‑dependent ferroptosis in nasopharyngeal carcinoma by modulating the Nrf2/HO‑1/GPX4 pathway. [PDF]

Int J Mol Med
Jin C, Li J, Han S, Bai C, Yang J, Wang Z.   +5 more
europepmc   +1 more source

Global Burden of Respiratory Tract Cancers From 1990 to 2021: Systematic Analysis of the Global Burden of Disease Study 2021

Thoracic Cancer, Volume 17, Issue 10, May 2026.
This study updates global trends in respiratory cancers from 1990 to 2021 with projections to 2040. Although age‐standardized rates are declining, the absolute numbers of new cases, deaths, and DALYs remain high. Smoking is the main cause, and health inequalities are widening, especially in high‐SDI regions.
Yuqing Wang, Yi Yao, Xinchen Sun, Di Yu, Chi Zhang   +4 more
wiley   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Relationship between allergic rhinitis and nasopharyngeal carcinoma. [PDF]

Medicine (Baltimore)
Wang QQ, Xu Y, Liu X, Jiang MX, Chen XY, Zou XK, Zhu XN, Ge HZ.   +7 more
europepmc   +1 more source

Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma

, 2016
S. Patel, Arnold C. Paulino, Danielle K. Johnston, Lee Wiederhold, Richard Castillo, Rajkumar Venkatramani   +5 more
openalex   +2 more sources

Multi-institutional deep learning for GTV segmentation and survival prediction in nasopharyngeal carcinoma. [PDF]

BMC Med Imaging
Yuce M, Erdogan SB, Akin A, Ozyar E, Gungor G, Guvendiren B, Tanoren B, Dumlu SN.   +7 more
europepmc   +1 more source

Pregnancy Incidence in Female Nasopharyngeal Carcinoma Survivors of Reproductive Age

, 2016
Bo‐Ching Lee, Ruoh‐Fang Yen, Cheng‐Li Lin, Ji‐An Liang, Ming‐Chia Lin, Chia‐Hung Kao   +5 more
openalex   +1 more source

Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal Carcinoma

Cancer Science, Volume 117, Issue 5, Page 1481-1496, May 2026.
The extent of EBV lytic replication in NPC has not been fully clarified. Our study demonstrated EBV replication and release in NPC and identified a significant association between expression of the late lytic protein gB and poor prognosis. These findings suggest that late lytic gene products may contribute to tumor progression and that gB represents a ...
Shigetaka Komura, Satoru Kondo, Hideya Kawasaki, Shinji Watanabe, Satoshi Yamada, Hirotomo Dochi, Han Gia Nguyen, Isao Ohta, Makiko Moriyama‐Kita, Masaki Fukuyo, Kousho Wakae, Yuki Kitagawa, Harue Mizokami, Luyao Liu, Nobuyuki Hirai, Eiji Kobayashi, Takayoshi Ueno, Yosuke Nakanishi, Kazuhira Endo, Hisashi Sugimoto, Naohiro Wakisaka, Rikinari Hanayama, Kiyoshi Misawa, Atsushi Kaneda, Tomokazu Yoshizaki   +24 more
wiley   +1 more source

Interpretable AI for treatment decision-making in immunoradiotherapy of locally advanced nasopharyngeal carcinoma. [PDF]

Front Oncol
Cao G, Zeng B, Yuan Z, Hu X, Ou H.
europepmc   +1 more source